| 國立成功大學 |
2023-01-12 |
Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective
|
Su;Hsuan-Yu;Yang;Chen-Yi;Ou;Huang-Tz;Chen;Shyi-Gen;Chen;Jui-Ching;Ho;Hui-Ju;Kuo;Shihchen |
| 國立成功大學 |
2007-09 |
Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
|
Sean D Sullivan; David L Veenstra; Chen, Pei-Jer; Chang, Ting-Tsung; Chuang, Wan-Long; Tsai, Chiaming; Patel, Kavita |
| 國立臺灣大學 |
2007 |
Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine Treatment in Patients with Hepatitis B E Antigen Positive Chronic Hepatitis B in Taiwan
|
陳培哲; 張定宗; 莊萬龍; CHEN, PEI-JER; CHANG, TING-TSUNG; CHUANG, WAN-LONG |
| 臺大學術典藏 |
2021-07-03T03:35:09Z |
Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
|
Sullivan S.D.; Veenstra D.L.; PEI-JER CHEN; Chang T.-T.; Chuang W.-L.; Tsai C.; Patel K. |
| 國立臺灣大學 |
2007-09 |
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.
|
Sullivan, SD; Veenstra, DL; Chen, PJ; Chang, TT; Chuang, WL; Tsai, C; Patel, K. |
| 國立成功大學 |
2021-03-10 |
Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan
|
Liao;Chia-Te;Hsieh;Tung-Han;Shih;Chia-Yin;Liu;Ping-Yen;Wang;Jung-Der |
| 臺大學術典藏 |
2022-08-19T00:20:36Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Cheng A.-L.; CHIUN HSU; Taiwan Cooperative Oncology Group; Chen P.-J.; Tsui C.-W.; Wu H.-Y.; Hsu Y.-T.; Chuang M.-H.; Hsiung C.A.; Liu T.-W.; Yang H.-C.; Hsiao C.-F.; Tsou H.-H. |
| 國家衛生研究院 |
2019-06-21 |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, HH;Yang, HC;Hsiao, CF;Hsiung, CA;Liu, TW;Chuang, MH;Wu, HY;Hsu, YT;Tsui, CW;Chen, PJ;Cheng, AL;Hsu, C; the Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 臺大學術典藏 |
2020-04-10T12:50:59Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.;Yang H.-C.;Hsiao C.-F.;Hsiung C.A.;Liu T.-W.;Chuang M.-H.;Wu H.-Y.;Hsu Y.-T.;Tsui C.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group; Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; Cheng A.-L.; Chiun Hsu; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-12T02:44:25Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H; | HUNG-CHIH YANG; | Hsiao C.-F; | Hsiung C.A; | Liu T.-W; | Chuang M.-H; | Wu H.-Y; | Hsu Y.-T; | Tsui C.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-03T03:33:29Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺北醫學大學 |
2009 |
Cost-Effectiveness of Prophylactic Human Papillomavirus (HPV) Vaccine for Prevention of Cervical Cancer in A Country with High Prevalence of HPV Infection
|
Pang-Hsiang Liu; Fu-Chang Hu; Chao-Wan Huang;Jung-Der Wang |
| 國家衛生研究院 |
2013-11 |
Cost-effectiveness of rotavirus vaccination programs in Taiwan
|
Chang, WC;Yen, C;Chi, CL;Wu, FT;Huang, YC;Lin, JS;Huang, FC;Tate, JE;Wu, HS;Hsiung, CA |
| 臺北醫學大學 |
2013 |
Cost-effectiveness of rotavirus vaccination programs in Taiwan
|
WC, Chang;Catherine, Yen;CL, Chia;FT, Wu;YC, Huang;JS, Line;FC, Huang;Jacqueline, Tate;HS, Wu;CA, Hsiung |
| 國立臺灣大學 |
2011 |
Cost-Effectiveness of Screening in an Outbreak
|
王怡人; 陳保中; 吳俞哖; 林水龍; WANG, I-JEN; CHEN, PAU-CHUNG; WU, YU-NIAN; LIN, SHOEI-LOONG |
| 臺大學術典藏 |
2018-09-10T08:49:02Z |
Cost-effectiveness of Screening in an Outbreak
|
王怡人;陳保中;吳俞哖;林水龍; Wang, I. J. and Huang, Y. C. and Chen, P. C. and Wu, Y. N. and Lin, S. L.; WANG, I-JEN;CHEN, PAU-CHUNG;WU, YU-NIAN;LIN, SHOEI-LOONG; Pau-Chung CHEN; WANG, I-JEN; CHEN, PAU-CHUNG; WU, YU-NIAN; LIN, SHOEI-LOONG; 林水龍 |
| 亞洲大學 |
2009 |
Cost-Effectiveness of Screening Syphilis among Pregnant Women in Mongolia
|
Enkhzaya chuluunbaatar |
| 國立成功大學 |
2022 |
Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world d
|
Peng, Z.-Y.;Yang, C.-T.;Ou, H.-T.;Kuo, S. |
| 國立成功大學 |
2022-07 |
Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world d
|
Peng;Zi-Yang;Yang;Chun-Ting;Ou;Huang-Tz;Kuo;Shihchen |
| 嘉南藥理大學 |
2016-05 |
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
|
Leung, Henry W. C.; Liu, Chung-Feng; Chan, Agnes L. F. |
| 臺大學術典藏 |
2020-12-17T02:40:26Z |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan
|
Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I.; FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W. |
| 臺大學術典藏 |
2020-10-12T10:15:04Z |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan
|
Inocencio, Timothy J; Wen, Yao-Chun; Yeh, Hung-I; Shau, Wen-Yi; Wu, Chia-Chao; Lu, Kuo-Cheng; Chen, Chin-I; Yeh, Shoou-Jeng; Tu, Shih-Te; Huey-Herng Sheu, Wayne; Hsieh, I-Chang; Shyu, Kou-Gi; Lin, Fang-Ju |
| 臺大學術典藏 |
2020 |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
|
FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W.; Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I. |
